Profile
Martin Holst Lange is Director at Pharmacosmos A since 2023.
Dr. Lange is Chief Scientific Officer & Executive VP at Novo Nordisk A since 2002.
Formerly, Dr. Lange was Medical Director at Novo Nordisk, Inc. from 2006 to 2008.
Dr. Lange was Director at Beta Bionics, Inc. from 2017 to 2020.
Education includes two doctorates from the University of Copenhagen, conferred in 1997 and 2004.
Martin Lange active positions
| Companies | Position | Start |
|---|---|---|
| NOVO NORDISK A/S | Chief Tech/Sci/R&D Officer | 07/08/2025 |
Pharmacosmos A/S
Pharmacosmos A/S BiotechnologyHealth Technology Engages in development of treatments for patients suffering from iron deficiency and anemia | Director/Board Member | 18/08/2023 |
Former positions of Martin Lange
| Companies | Position | End |
|---|---|---|
| BETA BIONICS, INC. | Director/Board Member | 20/02/2020 |
Novo Nordisk, Inc.
Novo Nordisk, Inc. BiotechnologyHealth Technology Develops biological medicines | Chief Tech/Sci/R&D Officer | 01/01/2008 |
Training of Martin Lange
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Novo Nordisk A/S
Novo Nordisk A/S Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for diabetes care | Health Technology |
University of Copenhagen
University of Copenhagen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novo Nordisk, Inc.
Novo Nordisk, Inc. BiotechnologyHealth Technology Develops biological medicines | Health Technology |
Pharmacosmos A/S
Pharmacosmos A/S BiotechnologyHealth Technology Engages in development of treatments for patients suffering from iron deficiency and anemia | Health Technology |
Beta Bionics, Inc.
Beta Bionics, Inc. Medical SpecialtiesHealth Technology Designs, develops, manufactures and markets medical devices for diabetes disease | Health Technology |
- Stock Market
- Insiders
- Martin Lange
















